Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A Sound Combination for Superior Miniaturized Assay Preparation

Published: Friday, January 11, 2013
Last Updated: Thursday, January 10, 2013
Bookmark and Share
Titian’s Mosaic™ sample management software seamlessly integrates with Labcyte automation and Echo® liquid handlers.

Titian Software and Labcyte Inc., have announced a smart integration of the Mosaic™ sample management suite with the Access™ workstation and POD™ automation platform - two Labcyte automation systems incorporating their revolutionary Echo® liquid handler.

The combination of Mosaic’s powerful software and flexible integration modules, coupled with the Echo system’s low volume acoustic liquid handling, enable fast, accurate, cost effective and fully traceable automated workflows for high-quality assay development and miniaturization.

Edmund Wilson, CEO of Titian, commented; “We have been working in close collaboration with the team at Labcyte to integrate the Mosaic web-based sample ordering facilities to the Access workstation”.

He continued; “One of the key objectives was to give users the convenience of requesting low volume assay-ready plates, with these being prepared automatically with very high precision.”

Mosaic easily and efficiently manages and tracks sample libraries with improved sample preservation and viability. Requestors can select individual substances, plates or substance sets for assay.

Mosaic allows assay plate formats to be defined and easily managed. Mosaic requests can also be configured as templates to precisely and repeatedly match the requirements of particular assays.

The order workflow is managed, ensuring that the correct items are brought to Labcyte systems to begin assay-ready plate preparation.

Labcyte automation systems incorporate Echo liquid handlers into small- and large- scale systems for walk-away sample processing.

Since the Echo liquid handler does not require the use of pipette tips, pin tools or nozzles it provides unsurpassed precision and accuracy.

With a range of device options and accessories, Labcyte automation systems adapt to the ever‐changing needs of assays in drug discovery, genomics, proteomics, and more.

Titian provides a driver module that transfers instruction files to the Labcyte Tempo automation control software - an intuitive platform to develop protocols for the Access and POD systems.

At the end of each acoustic transfer, the resulting changes in the inventory (including acoustic surveys of source well contents) are reflected in Mosaic, using the results data generated on the Labcyte systems, without operator interaction.

Labcyte Tempo software manages all tasks including system setup as well as all plate and liquid handling activities. After plate loading and sample transfer, the assay ready plates are sealed or lidded and stacked ready for delivery.

In addition to low volume plate replication and hit picking, the ability of the Echo system to transfer samples in as little as 2.5 nL permits a direct dilution of samples for dose-response assays; eliminating the cross-contamination and error propagation seen with traditional serial dilution methods.

“We have integrated our Echo liquid handler, automation, software, and consumables into cost-effective, high performance solutions targeting a range of applications,” says Mark Fischer‐Colbrie, CEO and president of Labcyte.

Fischer‐Colbrie continued, “The collaboration with Titian and their Mosaic software suite will allow our customers to seamlessly integrate sample management, processing, and analysis while improving results and saving costs.”

Titian Software is continually expanding the capabilities of the Mosaic sample management suite to meet current demands and, more importantly, new application developments.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

European Lead Factory - A Major New Drug Discovery Initiative
The European Lead Factory is the first of its kind and will provide a novel platform for innovative drug discovery.
Monday, January 27, 2014
Titian Software launches Mosaic 4.0
Proven sample management software now encompasses biological samples and reagents
Friday, April 23, 2010
Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!